On May 6, MAKO Surgical (NASDAQ: MAKO) reported its Q1 2010 operating results. The provider of robotic surgical platforms and minimally invasive surgery (MIS) implants announced that first quarter revenue totaled $7.2 million, a 94 percent increase over the same period in 2009. The company also sold four of its RIO surgical robotics platforms in Q1, bringing the total to 40, and announced that the volume of minimally invasive orthopedic knee procedures using MAKO technology (known as MAKOplasty) increased 30 percent quarter to quarter, and 176 percent over the first quarter of 2009. So naturally, shares of MAKO Surgical closed down 56 cents to $13.15.
The problem for Wall Street, it seems, is MAKO’s ongoing losses. In the first…
Robots based on a humanoid form factor will eventually join us at home, in the workplace and in public places. Here’s what’s news in humanoid robotics.
Stay up-to-date with robotics, follow the Robotics Blog by Mark Ingebretsen and guest contributors.
